Can a med spa in each state offer compounded semaglutide or tirzepatide
The same question, answered for 51 states from each state’s own law. States disagree on this, which is the point — an answer that is right in one is wrong next door. Every entry below is a statute or board rule we verified, most recently Sep 8, 2026.
Facility · part of The Practice Perimeter
Alabama
Nothing contained in this chapter shall prevent any licensed practitioner of the healing arts from personally compounding, dispensing, administering, or supplying to his or her patient drugs and medicines for their use.
Ala. Code § 34-23-11(a) (⛔ a practitioner’s own compounding is OUTSIDE the Pharmacy Act — but only PERSONALLY, and only for his or her own patient) · verified Sep 7, 2026
The full Alabama answer, with the rest of the section →Alaska
⛔ COMPOUNDED SEMAGLUTIDE IN ALASKA IS BOUNDED BY THE DEFINITION OF COMPOUNDING, WHICH HAS ONLY TWO LIMBS AND ONE OF THEM FORBIDS SALE. “compounding” means the preparation, mixing, assembling, packaging, or labeling of a drug or device (A) as the result of a practitioner's prescription drug order or initiative based on the relationship of the practitioner, patient, and pharmacist in the course of professional practice or (B) for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing Limb (A) requires a prescription order resting on a practitioner-patient-pharmacist relationship; limb (B) is research and is expressly not for sale or dispensing. A clinic buying compounded stock reaches neither on the face of the definition.
AS 08.80.480(4) (⛔ definition of “compounding” — and what it does NOT reach) · verified Sep 6, 2026
The full Alaska answer, with the rest of the section →Arizona
⚠️ COMPOUNDING IS A PHARMACIST ACT BY DEFINITION IN ARIZONA — AND THE DEFINITION EXPRESSLY COVERS OFFICE STOCK. “Compounding” means preparing, mixing, assembling, packaging or labeling a drug “BY A PHARMACIST OR AN INTERN OR PHARMACY TECHNICIAN UNDER THE PHARMACIST’S SUPERVISION, for the purpose of dispensing to a patient based on a valid prescription order”, and it INCLUDES preparing drugs “FOR ADMINISTRATION BY A MEDICAL PRACTITIONER TO THE MEDICAL PRACTITIONER’S PATIENT AND NOT FOR SALE OR DISPENSING”. Office stock to ADMINISTER is contemplated; office stock to SELL is not.
Ariz. Rev. Stat. § 32-1901 (“compounding”) · verified Sep 2, 2026
The full Arizona answer, with the rest of the section →Arkansas
⛔ ARKANSAS GENERALLY PROHIBITS COMPOUNDING A COPY OF A COMMERCIALLY AVAILABLE DRUG, AND SEMAGLUTIDE AND TIRZEPATIDE ARE COMMERCIALLY AVAILABLE PRODUCTS. Compounding a drug product that is commercially available in the marketplace or that is essentially a copy of a commercially available Food and Drug Administration-approved drug product is generally prohibited. (2) However, in special circumstances a pharmacist may compound an appropriate quantity of a drug that is only slightly different than a Food and Drug Administration-approved drug that is commercially available: (A) Based on documentation provided by the prescribing physician of a patient-specific medical need (e.g., the physician requests an alternate product due to hypersensitivity to excipients or preservative in the Food and Drug Administration-approved product, or the physician requests an effective alternate dosage form); or (B) If the drug product is not commercially available.
17 CAR § 160-2201(b)(1)-(2) (Standards for compounding and dispensing compounded products — copies of commercially available drugs) · verified Sep 7, 2026
The full Arkansas answer, with the rest of the section →California
THE STANDARD ITSELF REACHES ANY COMPOUNDING DESTINED FOR THIS STATE. “The compounding of drug preparations by a pharmacy FOR FURNISHING, DISTRIBUTION, OR USE IN THIS STATE SHALL BE CONSISTENT WITH STANDARDS ESTABLISHED IN THE PHARMACY COMPOUNDING CHAPTERS OF THE CURRENT VERSION OF THE UNITED STATES PHARMACOPEIA-NATIONAL FORMULARY, INCLUDING RELEVANT TESTING AND QUALITY ASSURANCE.” “For … use in this state” is what carries the duty across a state line to an out-of-state compounder.
Cal. Bus. & Prof. Code § 4126.8 · verified Sep 2, 2026 · read at Public.Law — California Codes
The full California answer, with the rest of the section →Colorado
⚠️ WHO MAY COMPOUND OR DISPENSE AT ALL, WHICH IS THE FIRST GATE ON A COMPOUNDED GLP-1. “ONLY A REGISTERED PRESCRIPTION DRUG OUTLET or other outlet registered pursuant to section 12-280-119 (1)(d) MAY COMPOUND OR DISPENSE A PRESCRIPTION.” A med spa is not a prescription drug outlet, so the default position is that it may do neither.
Colo. Rev. Stat. § 12-280-120(4) · verified Sep 2, 2026
The full Colorado answer, with the rest of the section →Connecticut
⛔ CONNECTICUT LIMITS WHAT A STERILE COMPOUNDING PHARMACY MAY DISPENSE WITHOUT A PATIENT-SPECIFIC ORDER. A sterile compounding pharmacy may only provide patient-specific sterile pharmaceuticals to patients, to practitioners of medicine, osteopathy, podiatry, dentistry or veterinary medicine, or to an acute care or long-term care hospital or health care facility licensed by the Department of Public Health. If a sterile compounding pharmacy provides sterile pharmaceuticals without a patient-specific prescription or medical order, the sterile compounding pharmacy shall also obtain a certificate of registration from the Department of Consumer Protection pursuant to section 21a-70 and any required federal license or registration. A sterile compounding pharmacy may prepare and maintain on-site inventory of sterile pharmaceuticals no greater than a thirty-day supply, calculated from the completion of compounding
Conn. Gen. Stat. §20-633b(d) (Sterile compounding pharmacies — patient-specific supply) · verified Sep 7, 2026
The full Connecticut answer, with the rest of the section →Delaware
⛔ DELAWARE IS ONE OF THE STATES THAT SAYS OFFICE USE OUT LOUD, WHICH MAKES ITS ANSWER ON COMPOUNDED SEMAGLUTIDE DIFFERENT FROM MOST. Nothing in this title is meant to limit a prescriber’s ability under pre-existing law to order a compounded medication for use in the prescriber’s practice, as permitted by State of Delaware and federal law. A prescriber may order compounded product FOR USE IN THE PRACTICE rather than against a named patient — but only so far as other Delaware and federal law already allow, so this preserves an existing ability and creates none.
24 Del. C. § 2502(7) (⛔ Delaware EXPRESSLY preserves office-use ordering by a prescriber) · verified Sep 6, 2026
The full Delaware answer, with the rest of the section →District of Columbia
Anticipatory compounding for later dispensing is inside the District's definition. Compounding - the preparation, mixing, assembling, packaging, or labeling of a drug or device as the result of a practitioner's prescription drug order or for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing. Compounding also includes the preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns.
22-B DCMR § 1999.1 (Pharmacies — Definitions: “Compounding”) · verified Sep 7, 2026
The full District of Columbia answer, with the rest of the section →Florida
⚠️ THE SUPPLIER OF A COMPOUNDED INJECTABLE NEEDS A FLORIDA PERMIT, AND THIS IS CHECKABLE. “IN ORDER TO SHIP, MAIL, DELIVER, OR DISPENSE, IN ANY MANNER, A COMPOUNDED STERILE PRODUCT INTO THIS STATE, a nonresident pharmacy registered under s. 465.0156, OR AN OUTSOURCING FACILITY, MUST HOLD A NONRESIDENT STERILE COMPOUNDING PERMIT.” Compounded semaglutide is a sterile product; a Florida practice buying it from out of state should ask to see this permit before the first delivery.
Fla. Stat. § 465.0158(1) · verified Sep 2, 2026
The full Florida answer, with the rest of the section →Georgia
⚠️ GEORGIA PROHIBITS OFFICE-USE COMPOUNDING FOR HUMAN PRACTITIONERS IN ONE SENTENCE. “THE DISTRIBUTION OF NON-PATIENT SPECIFIC COMPOUNDED PREPARATIONS FOR OFFICE USE BY A PRACTITIONER, EXCLUDING VETERINARIANS, IS PROHIBITED.” A Georgia med spa cannot lawfully receive compounded stock from a pharmacy to hold and use.
Ga. Comp. R. & Regs. 480-11 (compounding — office use) · verified Sep 2, 2026
The full Georgia answer, with the rest of the section →Hawaii
"Practice of pharmacy" means: (1) The interpretation and evaluation of prescription orders; the compounding, dispensing, and labeling of drugs and devices (except labeling by a manufacturer, packer, or distributor of nonprescription drugs and commercially legend drugs and devices); the participation in drug selection and drug utilization reviews; the proper and safe storage of drugs and devices and the maintenance of proper records therefor;
Haw. Rev. Stat. § 461-1 ("Practice of pharmacy" (1)) · verified Sep 8, 2026
The full Hawaii answer, with the rest of the section →Idaho
⛔ COMPOUNDED SEMAGLUTIDE OR TIRZEPATIDE EXISTS IN IDAHO ONLY AS A PREPARATION FOR ONE NAMED PATIENT, AND THE DEFINITION OF COMPOUNDING IS WHERE THE LAW SAYS SO. "Compounding" means the practice in which a pharmacist, a prescriber, or, in the case of an outsourcing facility, a person under the supervision of a pharmacist combines, mixes or alters ingredients of a drug to create a medication tailored to the needs of an individual patient. A prescriber is named in the definition, so compounding is not a pharmacist-only act here — but the preparation must be tailored to an individual patient, and this definition describes no office stock.
Idaho Code § 54-1704(7) (definition of “Compounding”) · verified Sep 6, 2026
The full Idaho answer, with the rest of the section →Illinois
⚠️ ILLINOIS PUTS TWO CONDITIONS ON COMPOUNDING A DRUG YOU COULD SIMPLY BUY, AND BOTH MUST HOLD. “COMMERCIALLY AVAILABLE PRODUCTS MAY BE COMPOUNDED FOR DISPENSING TO INDIVIDUAL PATIENTS ONLY IF ALL OF THE FOLLOWING CONDITIONS ARE MET: (i) THE COMMERCIAL PRODUCT IS NOT REASONABLY AVAILABLE FROM NORMAL DISTRIBUTION CHANNELS IN A TIMELY MANNER TO MEET THE PATIENT’S NEEDS and (ii) THE PRESCRIBING PRACTITIONER HAS REQUESTED THAT THE DRUG BE COMPOUNDED.” Availability is a SUPPLY-CHAIN test, not a price test — and the request must come from the prescriber.
225 ILCS 85/3 (“compounding”) · verified Sep 2, 2026
The full Illinois answer, with the rest of the section →Indiana
IN INDIANA, COMPOUNDING IS PHARMACY PRACTICE BY DEFINITION. The practice of pharmacy is performed by a pharmacist — or by a pharmacist intern or an unlicensed person the pharmacist SUPERVISES under section 18.5 — and it includes “THE COMPOUNDING, LABELING, ADMINISTERING, DISPENSING, OR SELLING OF DRUGS AND DEVICES … WHETHER DISPENSED UNDER A PRACTITIONER’S PRESCRIPTION OR DRUG ORDER OR SOLD OR GIVEN DIRECTLY TO THE ULTIMATE CONSUMER”, together with their proper and safe STORAGE AND DISTRIBUTION and the maintenance of records of receipt, storage, sale and dispensing.
Ind. Code § 25-26-13-11 · verified Sep 2, 2026
The full Indiana answer, with the rest of the section →Iowa
⛔ IOWA LICENSES THE EXACT ARRANGEMENT A MED SPA USES TO HOLD COMPOUNDED SEMAGLUTIDE, AND NAMES IT. Any compounding facility that is registered as an outsourcing facility, as defined in 21 U.S.C. §353b, that distributes sterile compounded human drug products without a patient-specific prescription to an authorized agent or practitioner in this state shall obtain an outsourcing facility license from the board prior to engaging in such distribution. Buying compounded semaglutide as office stock — that is, without a prescription naming the patient — is distribution the supplier must hold an Iowa outsourcing facility license to make.
Iowa Code § 155A.13C(1) (⛔ office stock without a patient-specific prescription is a LICENSED activity) · verified Sep 6, 2026
The full Iowa answer, with the rest of the section →Kansas
⛔ THIS IS THE COMPOUNDED-SEMAGLUTIDE QUESTION ANSWERED INSIDE THE DEFINITION ITSELF, AND KANSAS SETS A TEST THE DRUG’S OWN AVAILABILITY DECIDES. Compounding is the combining of components into a compounded preparation "Compounding" means the combining of components into a compounded preparation under either of the following conditions: (A) As the result of a practitioner's prescription drug order or initiative based on the practitioner-patient-pharmacist relationship in the course of professional practice to meet the specialized medical need of an individual patient of the practitioner that cannot be filled by an FDA-approved drug Semaglutide and tirzepatide ARE available as FDA-approved drugs, so in Kansas a compounded version has to answer a specialized medical need of an identified patient that the approved product cannot meet — commercial preference or price is not that need.
K.S.A. § 65-1626(k)(1)(A) (⛔ compounding must meet a need an FDA-APPROVED DRUG CANNOT FILL) · verified Sep 6, 2026
The full Kansas answer, with the rest of the section →Kentucky
⛔ KENTUCKY BARS COMPOUNDING AN ESSENTIAL COPY OF A COMMERCIALLY AVAILABLE DRUG UNLESS FEDERAL LAW ALLOWS IT — AND A COMPOUNDED SEMAGLUTIDE OR TIRZEPATIDE PREPARATION IS SUCH A COPY WHILE THE APPROVED PRODUCT IS AVAILABLE. Non-sterile and sterile preparations compounded for human use shall: Not be essential copies of a commercially available drug product unless authorized by 21 U.S.C. 353(a).
201 KAR 2:076 Section 3(5)(b) (Compounding — standards; essential copies) · verified Sep 7, 2026
The full Kentucky answer, with the rest of the section →Louisiana
⛔ LOUISIANA EXCLUDES COPIES OF A COMMERCIAL PRODUCT FROM COMPOUNDING BY DEFINITION, AND SEMAGLUTIDE AND TIRZEPATIDE ARE COMMERCIALLY AVAILABLE PRODUCTS. Compounding does not include the compounding of drug products that are essentially copies of a commercially available product.
La. Admin. Code tit. 46, pt. LIII, § 2533(A) (Definitions — Compounding; ⛔ copies of a commercially available product are NOT compounding) · verified Sep 7, 2026
The full Louisiana answer, with the rest of the section →Maine
⛔ MAINE ENUMERATES WHAT COMPOUNDING MAY BE FOR, AND THE ONLY NON-PATIENT-SPECIFIC LIMB IS VETERINARY. "Compounding" means the preparation, mixing, assembling, packaging or labeling of a drug or device by a pharmacist: A. For the pharmacist's patient for dispensing as the result of a practitioner's prescription drug order; The act is a pharmacist's to begin with, and limb A ties it to that pharmacist's own patient against a prescription order.
32 M.R.S. § 13702-A(4) (⛔ compounding is a PHARMACIST’s act, and every limb is patient-specific but one) · verified Sep 6, 2026
The full Maine answer, with the rest of the section →Maryland
Anticipatory compounding for later dispensing is inside Maryland's definition. “Compounding” means the preparation, mixing, assembling, packaging, or labeling of a drug: (a) As the result of a practitioner’s prescription drug order or initiative based on the practitioner/patient relationship in the course of professional practice; (b) For the purpose of, or incidental to, research, teaching, or chemical analysis and not for the sale or dispensing of the drug or device; or (c) In anticipation of a prescription drug order based on routine, regularly observed prescribing patterns.
Md. Code Regs. 10.34.19.03(B)(9) (Sterile Pharmaceutical Compounding — “Compounding” defined) · verified Sep 7, 2026
The full Maryland answer, with the rest of the section →Massachusetts
⚠️ MASSACHUSETTS LICENSES STERILE COMPOUNDING SEPARATELY, AND THE LICENSE STACKS. “The board SHALL ESTABLISH A CATEGORY OF PHARMACY LICENSURE FOR RETAIL PHARMACIES ENGAGED IN STERILE COMPOUNDING. A retail sterile compounding pharmacy license issued by the board SHALL BE OBTAINED IN ADDITION TO AND NOT IN PLACE OF ANY OTHER PERMIT OR LICENSE A PHARMACY HOLDS.” Compounded semaglutide is a sterile preparation, so a Massachusetts practice’s supplier needs this license on top of its pharmacy permit.
Mass. Gen. Laws ch. 112, § 39G(a)(1)–(2) · verified Sep 2, 2026
The full Massachusetts answer, with the rest of the section →Michigan
⚠️ MICHIGAN REQUIRES A LICENSE TO COMPOUND AT ALL, AND A SECOND AUTHORIZATION ON TOP OF IT. “To do business in this state, A PERSON THAT PROVIDES COMPOUNDING SERVICES MUST BE LICENSED AS A PHARMACY OR MANUFACTURER under this part AND, IF A PHARMACY, AUTHORIZED TO PROVIDE COMPOUNDING SERVICES under this section and sections 17748a and 17748b.” The same subsection opens by requiring that “A PHARMACY, MANUFACTURER, WHOLESALE DISTRIBUTOR, OR WHOLESALE DISTRIBUTOR-BROKER, WHETHER OR NOT LOCATED IN THIS STATE, MUST BE LICENSED under this part” — so every link in the chain that distributes a compounded drug into Michigan is licensed here. A pharmacy license alone does not by itself carry compounding authority.
Mich. Comp. Laws § 333.17748(1) · verified Sep 2, 2026 · read at Internet Archive snapshot — evidence of a page, not the current rule
The full Michigan answer, with the rest of the section →Minnesota
⚠️ COMPOUNDED SEMAGLUTIDE IS PATIENT-SPECIFIC BY DEFINITION IN MINNESOTA. “Compounding” means preparing, mixing, assembling, packaging, and labeling a drug FOR AN IDENTIFIED INDIVIDUAL PATIENT AS A RESULT OF A PRACTITIONER’S PRESCRIPTION DRUG ORDER — and the definition closes with the general rule: “ALL COMPOUNDING, REGARDLESS OF THE TYPE OF PRODUCT, MUST BE DONE PURSUANT TO A PRESCRIPTION DRUG ORDER unless otherwise permitted in this chapter or by the rules of the board.” A med spa cannot lawfully stock generic compounded vials against future demand.
Minn. Stat. § 151.01, subd. 35 · verified Sep 2, 2026
The full Minnesota answer, with the rest of the section →Mississippi
Mississippi’s pharmacy act defines the practice of pharmacy to include compounding and dispensing: it means a health care service that includes, but is not limited to, the compounding, dispensing, and labeling of drugs or devices; interpreting and evaluating prescriptions; administering and distributing drugs and devices;
Miss. Code Ann. § 73-21-73(z) (“Practice of pharmacy”) · verified Sep 8, 2026
The full Mississippi answer, with the rest of the section →Missouri
⛔ MISSOURI ALLOWS COMPOUNDED STOCK AHEAD OF THE ORDER AND TIES IT TO A RELATIONSHIP THAT ALREADY EXISTS, WHICH IS WHERE COMPOUNDED SEMAGLUTIDE FOR A NEW CLINIC FAILS. Pharmacists may compound preparations in limited quantities prior to receiving a valid prescription based on a history of receiving valid prescriptions that have been generated solely with an established pharmacist/patient/ prescriber relationship. The justification is a history of real prescriptions inside an established pharmacist/patient/prescriber relationship — not projected demand, and not a clinic’s intention to sell.
20 CSR 2220-2.400(C) (⛔ stock ahead of the prescription needs a HISTORY of that prescription) · verified Sep 7, 2026
The full Missouri answer, with the rest of the section →Montana
"Compounding" means the preparation, mixing, assembling, packaging, or labeling of a drug or device based on: (a) a practitioner's prescription drug order; (b) a professional practice relationship between a practitioner, pharmacist, and patient; (c) research, instruction, or chemical analysis, but not for sale or dispensing; (d) the preparation of drugs or devices based on routine, regularly observed prescribing patterns; or (e) the preparation of drugs based on a facility being registered as an outsourcing facility with the FDA.
Mont. Code Ann. § 37-7-101(9) · verified Sep 8, 2026
The full Montana answer, with the rest of the section →Nebraska
⛔ NEBRASKA ALLOWS COMPOUNDING FOR OFFICE USE BUT NOT A COPY OF AN APPROVED DRUG, WHICH IS WHAT A COMPOUNDED SEMAGLUTIDE OR TIRZEPATIDE PRODUCT IS OUTSIDE A SHORTAGE. No person shall compound: (a) A drug that has been identified by the federal Food and Drug Administration as withdrawn or removed from the market because the drug was found to be unsafe or ineffective; (b) A drug that is essentially a copy of an approved drug unless there is a drug shortage as determined by the board or unless a patient has an allergic reaction to the approved drug; or (c) A drug that has been identified by the federal Food and Drug Administration or the board as a product which may not be compounded.
Neb. Rev. Stat. §38-2867.01(5) (Authority to compound — prohibited acts) · verified Sep 7, 2026
The full Nebraska answer, with the rest of the section →Nevada
Except as otherwise provided in subsection 2, an outsourcing facility is not required to be licensed as a pharmacy. An outsourcing facility may dispense dangerous drugs or controlled substances for identified individual patients pursuant to a prescription only if the outsourcing facility is licensed by the Board as a pharmacy in accordance with NRS 639.230 or 639.2328.
Nev. Admin. Code §639.6916 (Outsourcing facilities — when licensure as pharmacy required) · verified Sep 7, 2026
The full Nevada answer, with the rest of the section →New Hampshire
⛔ NEW HAMPSHIRE BARS COMPOUNDING A STERILE COPY OF A COMMERCIALLY AVAILABLE FDA-APPROVED PRODUCT, WHICH IS WHAT A COMPOUNDED SEMAGLUTIDE OR TIRZEPATIDE INJECTION IS WHILE THE APPROVED PRODUCT IS ON THE MARKET. A compounder shall not compound a sterile product of an FDA-approved product when the product is commercially available. (f) When no commercial source of a sterile product exists, such as being listed on the FDA backorder list, the compounder shall only use USP or other USP recognized grades such as BP, JP, EP, bulk ingredients obtained from a good manufacturing practice compliant supplier.
N.H. Code Admin. R. Ph 404.04(e)-(f) (Regulatory Requirements for Sterile Compounding) · verified Sep 7, 2026
The full New Hampshire answer, with the rest of the section →New Jersey
⚠️ NEW JERSEY BARS COMPOUNDED STERILE STOCK FOR HUMAN PRACTICE, AND PERMITS IT FOR ANIMALS. “IN THE ABSENCE OF A VALID PATIENT-SPECIFIC PRESCRIPTION OR MEDICATION ORDER, pharmacists, pharmacy technicians, pharmacy interns, and pharmacy externs SHALL NOT PREPARE COMPOUNDED STERILE PREPARATIONS FOR HUMAN USE FOR A LICENSED PRESCRIBER TO USE IN HIS OR HER PRACTICE, EXCEPT TO THE EXTENT PERMITTED BY FEDERAL LAW.” The very next sentence lets a pharmacy prepare them for a prescriber “FOR NON-HUMAN USE … WITHOUT A PRESCRIPTION”. The federal exception is the 503B door.
N.J.A.C. 13:39-11.18 · verified Sep 2, 2026 · read at Internet Archive snapshot — evidence of a page, not the current rule
The full New Jersey answer, with the rest of the section →New Mexico
⛔ NEW MEXICO LETS A PHARMACY COMPOUND A COMMERCIALLY AVAILABLE PRODUCT FOR DISPENSING ONLY ON STATED CONDITIONS, WHICH IS THE COMPOUNDED-SEMAGLUTIDE QUESTION IN ONE PARAGRAPH. Commercially available product may be compounded for dispensing to individual patients provided the following conditions are met: (a) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet patient’s needs; and (b) the prescribing practitioner has requested that the drug be compounded; or (c) if the compounded product is changed to produce for that patient a significant difference, as authorized by the prescriber, between the compounded drug and the comparable commercially available drug product, or if use of the compounded product is in the best interest of the patient; when a compounded product is to be dispensed in place of a commercially available product, the prescriber and patient shall be informed that the product will be compounded.
16.19.30.9(A)(3) NMAC (Compounding of Non-Sterile Pharmaceuticals — commercially available products) · verified Sep 8, 2026
The full New Mexico answer, with the rest of the section →New York
THE BASELINE IS A PHARMACIST AND A PRESCRIPTION. “No drug for which a prescription is required … shall be distributed or dispensed to any person EXCEPT UPON A PRESCRIPTION written by a person legally authorized to issue such prescription. SUCH DRUG SHALL BE COMPOUNDED OR DISPENSED BY A LICENSED PHARMACIST”, labeled with the dispensing establishment owner’s name and address, THE DATE COMPOUNDED, the prescription number, the prescriber, the patient’s name and address, and the directions for use.
N.Y. Educ. Law § 6810(1) · verified Sep 2, 2026
The full New York answer, with the rest of the section →North Carolina
NORTH CAROLINA DEFINES COMPOUNDING BROADLY ENOUGH TO CATCH A DILUTION. “Compounding” means “TAKING TWO OR MORE INGREDIENTS AND COMBINING THEM INTO A DOSAGE FORM OF A DRUG, EXCLUSIVE OF COMPOUNDING BY A DRUG MANUFACTURER, DISTRIBUTOR, OR PACKER.” No exception for reconstitution to the label, and no minimum quantity — two ingredients into a dosage form is the whole test.
N.C. Gen. Stat. § 90-85.3(c) · verified Sep 2, 2026
The full North Carolina answer, with the rest of the section →North Dakota
⛔ NORTH DAKOTA ANSWERS THE COMPOUNDED-SEMAGLUTIDE QUESTION IN THE DEFINITION, AND NEITHER LIMB REACHES A CLINIC BUYING STOCK. "Compounding" means the preparation, mixing, assembling, packaging, or labeling of a drug or device: a. As the result of a practitioner's prescription drug order or initiative based on the practitioner, patient, and pharmacist relationship in the course of professional practice; or b. For the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing. Limb (a) needs a prescription order resting on the practitioner-patient-pharmacist relationship; limb (b) is research and is expressly not for sale or dispensing.
N.D. Cent. Code § 43-15-01 (⛔ definition of “Compounding” — two limbs, one of them not for sale) · verified Sep 6, 2026
The full North Dakota answer, with the rest of the section →Ohio
⚠️ OHIO DOES LICENSE THE PREMISES — JUST NOT THROUGH THE MEDICAL BOARD. A manufacturer, OUTSOURCING FACILITY, third-party logistics provider, repackager or wholesale distributor may sell or distribute dangerous drugs only to A LICENSED TERMINAL DISTRIBUTOR OF DANGEROUS DRUGS, or to a person exempt from that licensure under § 4729.541. Whether a med spa may take delivery of a drug at all turns on which of those two it is.
Ohio Rev. Code § 4729.51(B) · verified Sep 2, 2026
The full Ohio answer, with the rest of the section →Oklahoma
⛔ OKLAHOMA ANSWERS THE COMPOUNDED-SEMAGLUTIDE QUESTION IN THE PHARMACY ACT’S DEFINITIONS, AND ITS DEFINITION IS BROADER THAN MOST. "Compounding" means the combining, admixing, mixing, diluting, pooling, reconstituting or otherwise altering of a drug or bulk drug substance to create a drug. Compounding includes the preparation of drugs or devices in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns The definition does not turn on an individual patient’s specialized need, and it expressly reaches stock prepared ahead of the order — but the anticipation must rest on prescribing already observed, not on expected demand.
Okla. Stat. tit. 59, § 353.1(8) (⛔ definition of “Compounding” — and the anticipatory limb) · verified Sep 6, 2026
The full Oklahoma answer, with the rest of the section →Oregon
“Manufacture” means the production, preparation, propagation, compounding, conversion or processing of a device or a drug, either directly or indirectly by extraction from substances of natural origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis and includes any packaging or repackaging of the substances or labeling or relabeling of its container, except that this term does not include the preparation or compounding of a drug by an individual for their own use or the preparation, compounding, packaging or labeling of a drug: (a) By a practitioner as an incident to administering or dispensing of a drug in the course of professional practice.
Or. Rev. Stat. §689.005(20) (“Manufacture” defined — practitioner compounding incident to administering or dispensing excluded) · verified Sep 7, 2026
The full Oregon answer, with the rest of the section →Pennsylvania
⚠️ AND THE PROHIBITION IS THE WHOLE GLP-1 QUESTION IN ONE CLAUSE. “Pharmacists MAY NOT COMPOUND … DRUGS THAT ARE ESSENTIALLY COPIES OF A COMMERCIALLY AVAILABLE DRUG PRODUCT, except as provided in section 503a(b)(1)(D) of the Federal Food, Drug, and Cosmetic Act.” Where the branded GLP-1 can be obtained, a compounded version of it is an essential copy and Pennsylvania forbids compounding it — no quantity limit or supervision arrangement cures that.
49 Pa. Code § 27.602(2) · verified Sep 2, 2026 · read at Cornell Legal Information Institute
The full Pennsylvania answer, with the rest of the section →Rhode Island
⛔ RHODE ISLAND ANSWERS THE COMPOUNDED-SEMAGLUTIDE QUESTION WITH A SENTENCE ABOUT COPIES. Compounding does not mean the routine preparation, mixing, or assembling of drug products that are essentially copies of a commercially available product. Semaglutide and tirzepatide are commercially available products, so a compounded version prepared as a routine copy of one falls outside what Rhode Island calls compounding at all.
R.I. Gen. Laws § 5-19.1-2 (⛔ compounding is NOT copies of a commercially available product) · verified Sep 6, 2026
The full Rhode Island answer, with the rest of the section →South Carolina
"Outsourcing facility" means a facility registered with the United States Food and Drug Administration to operate under Section 503B of the federal Food and Cosmetic Act.
S.C. Code §40-43-30(39) (definition of “Outsourcing facility” — added by 2024 Act No. 132, the supply route for non-patient-specific compounded stock) · verified Sep 7, 2026
The full South Carolina answer, with the rest of the section →South Dakota
⛔ SOUTH DAKOTA ANSWERS THE COMPOUNDED-SEMAGLUTIDE QUESTION IN THE DEFINITION, AND THE SECOND LIMB RULES OUT THE COMMERCIAL ROUTE ON ITS FACE. "Compounding," the preparation, mixing, assembling, packaging, or labeling of a drug or drug device, as the result of a practitioner's prescription drug order or an initiative based on the pharmacist, patient, and practitioner relationship in the course of professional practice, or for the purpose of or as an incident to research, teaching, or chemical analysis, and not for sale or dispensing. A compounded preparation must answer a prescription drug order resting on the pharmacist-patient-practitioner relationship; the only alternative limb is research, and it excludes sale and dispensing.
S.D. Codified Laws § 36-11-2(4) (⛔ definition of “Compounding” — and the limb that forbids sale) · verified Sep 6, 2026
The full South Dakota answer, with the rest of the section →Tennessee
TENNESSEE BINDS STERILE COMPOUNDING TO USP AND SAYS SO TWICE. “ALL STERILE PRODUCTS SHALL BE PREPARED IN COMPLIANCE WITH APPLICABLE USP STANDARDS FOR PHARMACEUTICAL COMPOUNDING”, and separately “ANY FACILITY THAT COMPOUNDS STERILE PRODUCTS SHALL COMPLY WITH APPLICABLE USP STANDARDS.” Compounded injectables are sterile products, so USP is the operative standard behind any compounded GLP-1 a Tennessee practice administers.
Tenn. Comp. R. & Regs. 1140-07-.02(1); 1140-07-.04(1) · verified Sep 2, 2026
The full Tennessee answer, with the rest of the section →Texas
⚠️ TEXAS PERMITS OFFICE-USE COMPOUNDING OUTRIGHT, WHICH FEW STATES DO. “A PHARMACY MAY DISPENSE AND DELIVER A REASONABLE QUANTITY OF A COMPOUNDED DRUG TO A PRACTITIONER FOR OFFICE USE BY THE PRACTITIONER in accordance with this chapter.” There is no commercial-availability condition and no patient-specific prescription requirement — the limit is the phrase “reasonable quantity”.
Tex. Occ. Code § 562.152 · verified Sep 2, 2026
The full Texas answer, with the rest of the section →Utah
⛔ UTAH ANSWERS THE COMPOUNDED-SEMAGLUTIDE QUESTION BY EXCLUSION, AND THE EXCLUSION IS THE SHARPEST ON THIS PASS. "Compounding" does not include the preparation by a pharmacist or pharmacy intern of any prescription drug in a dosage form which is regularly and commonly available from a manufacturer in quantities and strengths prescribed by a practitioner Semaglutide and tirzepatide are regularly and commonly available from their manufacturers, so preparing them in the marketed dosage form is not compounding in Utah at all — it falls outside the definition rather than inside it on conditions.
Utah Code § 58-17b-102(18)(b)(ii) (⛔ preparing a commercially available drug is NOT compounding) · verified Sep 7, 2026
The full Utah answer, with the rest of the section →Vermont
Vermont licenses compounding and 503B outsourcing as classes of drug outlet: Each drug outlet shall apply for a license in one or more of the following classifications: (1) Retail. (2) Institutional. (3) Manufacturer. (4) Wholesale distributor. (5) Investigative and research projects. (6) Compounding. (7) Outsourcing. (8) Home infusion. (9) Nuclear. (10) Third-party logistics provider.
Vt. Stat. tit. 26, §2061(b) (Drug outlets — registration and licensure classifications) · verified Sep 7, 2026
The full Vermont answer, with the rest of the section →Virginia
VIRGINIA COMPOUNDS PATIENT BY PATIENT, AND TIES IT BACK TO THE EXAMINATION DUTY. A pharmacist may compound when dispensing is “(i) PURSUANT TO VALID PRESCRIPTIONS FOR SPECIFIC PATIENTS and (ii) CONSISTENT WITH THE PROVISIONS OF § 54.1-3303 relating to the issuance of prescriptions and the dispensing of drugs” — which is the bona fide practitioner-patient relationship, examination included. The two questions are one question in Virginia.
Va. Code § 54.1-3410.2(A) · verified Sep 2, 2026
The full Virginia answer, with the rest of the section →Washington
⚠️ AND WASHINGTON EXPRESSLY CONTEMPLATES OFFICE STOCK, THEN BINDS IT TO USP. “Any medicinal products that are compounded FOR PATIENT ADMINISTRATION OR DISTRIBUTION TO A LICENSED PRACTITIONER FOR PATIENT USE OR ADMINISTRATION shall, AT A MINIMUM, MEET THE STANDARDS OF THE OFFICIAL UNITED STATES PHARMACOPEIA as it applies to nonsterile products and STERILE ADMINISTERED PRODUCTS.” Distribution to a practitioner for office use is assumed lawful by the text; what the statute regulates is the standard it must meet.
Wash. Rev. Code § 18.64.270(2) · verified Sep 2, 2026
The full Washington answer, with the rest of the section →West Virginia
⛔ WEST VIRGINIA PUTS THE SALE CONDITION INSIDE THE FIRST LIMB RATHER THAN LEAVING IT TO INFERENCE. “Compounding” means: (A) The preparation, mixing, assembling, packaging, or labeling of a drug or device: (i) As the result of a practitioner’s prescription drug order or initiative based on the practitioner/patient/pharmacist relationship in the course of professional practice for sale or dispensing; or (ii) For the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing Compounding may be for sale or dispensing ONLY on limb (i) — which requires a prescription drug order resting on the practitioner/patient/pharmacist relationship. The research limb (ii) is expressly not for sale or dispensing, so it is no route to stock.
W. Va. Code § 30-5-4 (⛔ definition of “Compounding” — the two limbs, and which one permits sale) · verified Sep 6, 2026
The full West Virginia answer, with the rest of the section →Wisconsin
WISCONSIN LETS THE PRACTITIONER COMPOUND, WHICH MANY STATES DO NOT. “No person other than A PHARMACIST OR PRACTITIONER OR THEIR AGENTS AND EMPLOYEES AS DIRECTED, SUPERVISED, AND INSPECTED BY THE PHARMACIST OR PRACTITIONER, including pharmacy technicians, MAY PREPARE, COMPOUND, DISPENSE, OR PREPARE FOR DELIVERY FOR A PATIENT ANY PRESCRIPTION DRUG.” Three verbs govern the delegate — directed, supervised AND inspected — so an unsupervised staff member preparing an injectable is outside the statute.
Wis. Stat. § 450.11(3) · verified Sep 2, 2026
The full Wisconsin answer, with the rest of the section →Wyoming
⛔ WYOMING'S PHARMACY RULES REFUSE THE ORDER A MED SPA WOULD USE TO STOCK COMPOUNDED SEMAGLUTIDE. A prescription may not be dispensed to a practitioner based on an order that is not issued for one specific patient. A prescription order for "office use" is not a valid order.
Wyo. Bd. of Pharmacy Rules ch. 2 § 6(d) (Requirements for issuing valid prescriptions; ref. 059.0001.2.05242023) · verified Sep 7, 2026
The full Wyoming answer, with the rest of the section →Which states this covers
51 of the 51 states for which we publish statute-cited rules. That is not every state, and nothing above should be read as describing one that is not listed — the answer genuinely differs, so a neighbouring state is not a guide. We monitor all 50 state legislatures plus the FDA and the Federal Register daily; the cited rule set is narrower than the monitoring and is growing on its own timetable.
What we track in every state →Get regulatory changes as they publish
We scan all 50 state legislatures daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
MedSpaRadar is regulatory monitoring and reference, not legal, medical, or compliance advice. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts. Legislative data via LegiScan (CC BY 4.0).